Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. April 2025 07:00 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
21. April 2025 08:00 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Stereotaxis to host live demo of its most accessible surgical robot yet, GenesisX, at HRS 2025.
19. März 2025 08:01 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA...
10. März 2025 08:02 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Present at 37th Annual Roth Conference

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
03. März 2025 07:32 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
03. März 2025 07:31 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
03. März 2025 07:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Reports 2024 Full Year Financial Results

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
25. Februar 2025 08:03 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

ST. LOUIS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
03. Februar 2025 16:05 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

ST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
30. Januar 2025 08:09 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Announces First GenesisX Robotic System Order

ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...

Vorherige Seite

Nächste Seite